Merck sets up Organon spinout with a women’s health medical device acquisition March 30, 2021 Auto Bot Acquisitions, BioPharma, biopharma nl, Kenilworth, Medical Devices, Merck, New Jersey, womens health 0 Merck agreed to pay $215 million up front to acquire Alydia Health, a startup that has commercialized a medical device that controls bleeding during childbirth. That product will join the portfolio of Merck spinout company Organon.